When the HMDMs were co-treated with resveratrol and tumor-conditioned medium (TCM), the secretion of IL-10, one of the M2-phenotype markers, was significantly lowered in comparison to the group only treated with TCM. This evidence concerns the gene IL10 and neoplasm.